We found a rather narrow range of other genes (KMT2D, FBXW7, GNAS, ARID1A, NF1 and CTNNB1) harbouring mutations in 6–12% of the patients and a long tail of cancer genes with mutations in <6%. Here, CTNNB1 is linked to cancer.